Overview
CNTA market data
Price History
CNTA price chart
Valuation & Profitability
- P/E (TTM)
- — Trailing twelve-month price-to-earnings ratio. Higher means the market is pricing in more growth. Negative or missing when earnings are negative.
- Forward P/E
- — P/E based on consensus forward EPS estimates. Lower versus trailing implies expected earnings growth.
- EPS (TTM)
- -$1.46 Diluted earnings per share over the trailing twelve months.
- Beta
- 0.36 Volatility relative to the index. 1.00 equals market, above 1 amplifies the broad-market move, below 1 dampens it.
- Dividend Yield
- — Annual dividend per share divided by current price. Zero or blank when the company does not pay a dividend.
- Profit Margin
- — Net income divided by revenue. Comparable within a sector, less so across sectors.
- 52w range
- $15.01 – $40.56 Lowest and highest closing prices over the past 52 weeks.
- Analyst Target
- — Mean of sell-side analyst 12-month price targets. Use as a sentiment gauge; targets are biased upward in aggregate.
Display-only. Refreshed once per symbol per 24 hours · source Twelve Data /statistics · market cap $6.3K · P/B 6.31.
Company news
8-K filing — Centessa Pharmaceuticals plc (CNTA)SEC EDGAR · Jun 24, 2026, 12:56 PM
Centessa Pharmaceuticals' Proposed $38/Share Acquisition By Eli Lilly Receives High Court Of Justice Of England And Wales ApprovalBenzinga · Jun 22, 2026, 8:10 PM
$HAREHOLDER ALERT: The M&A Class Action Firm Continues to Investigate the Merger—RAMP, NEE, CNTA, and HCBNGlobenewswire Inc · May 27, 2026, 3:15 PM